All episodes
Treating Psychiatric Conditions with Tripless Psychedelics
How AI Is Finding Its Way into Unexpected Places in Biopharma Companies
Searching the Dark Matter of the Proteome to Develop New Therapies
The Year in Biotech and What’s Ahead in 2023
Targeting a Novel Checkpoint to Treat Cancer and Autoimmune Conditions
The Growing Need for Biosecurity Vigilance
Enlisting Next-Generation Cytokine Immunotherapies in the Fight Against Cancer
Engineering Safer and More Effective Cell Therapies
Changing Drug Discovery for Neuropsychiatric Disorders with Phenotypic Screens
Using Virtual Reality-Guided Mindfulness to Treat Chronic Pain in Cancer Patients
Activating the Adaptive and Innate Immune Systems to Fight Cancer
A Longevity Fund Focused on Young Companies
Learning from “Elite” Responders to Develop Better Immunotherapies
Bringing Precision Medicine to the Treatment of Obesity
Expanding the Promise of RNA Therapies
Triggering a Systemic Immune Response Against Cancer
Targeting RNA Dysregulation in Cancer
Building a Pipeline of Next-Generation Kinase Inhibitors
Rethinking How Cell and Gene Therapies Are Made to Improve Accessibility
Developing Next-Generation Radiopharmaceuticals
Why Great Science and Data Aren’t Enough
Targeting Sugars that Let Cancers Evade the Immune System
Engineering Stem Cells to Withstand Targeted Therapies
Targeting a Convergence of Signaling Pathways that Drive the Growth and Spread of Cancer
Moving from Preservation to Restoration with Off-the-Shelf Cell Therapies
Using Gene Therapies to Treat Chronic, Inflammatory Conditions
Unlocking the Full Potential of Antibody Therapies
Combatting Superbugs and Emerging Viruses
How a Plant-Derived Gel Halts Bleeding in Seconds
Exploiting a Vulnerability in Cancers
Democratizing AI
A Rapid Onset Nasal Spray to Treat Mental Health Conditions
A Regenerative Medicine Company Puts Its Off-the-Shelf Vessel Replacements to the Test in Ukraine
Battling Resistance in Tumors with “Pan-Variant” Kinase Inhibitors
Treating Disease by Editing Genes in the Microbiome
Embracing the Promise of Natural Killer Cells in the Fight Against Cancer
Addressing Neurodegenerative Disease by Suppressing a Hyper Immune Response
Bringing Precision Medicine to Psychiatry
Attacking Neurodegenerative Diseases with Protein Degraders
Restoring Immune Activity While Suppressing Cancer Proliferation
A New Model for Preventing Life-Threatening Blood Clots
The Race to Live Forever
A Model for Moving from Breakthrough to Blockbuster
Building the Next-Generation of Cell and Gene Therapies
Building Small Molecule Drugs that Are Superior to Biologics
A New Class of Cancer Therapies Targets Solid Tumors with a Dual Action
A Pursuit of Off-The-Shelf CAR-T Therapies
Mapping the Human Proteome
Gene Therapy Provides Hope to Hemophilia B Patients
Making Data-Driven Medicine a Reality
A Neuroscientist Turned Venture Investor Discusses TechBio Investing
A Nonprofit Seeks to Make Cell and Gene Therapies Affordable Worldwide
Disposing Toxic Proteins to Treat Neurodegenerative Diseases
Repurposing a Drug for Parasitic Infections as a Targeted GI Therapy
Targeting Chronic, Low-Grade Inflammation to Address Diseases of Aging
The Year in Biotech and What’s Ahead in 2022
Restoring the Guardian of the Genome to Fight Tumors
Advancing a Cell Therapy with the Potential to Cure HIV
Harnessing More Efficient Organisms to Reshore BioManufacutring
Using Digital Health Technology to Bring the Trial to the Patient
Using the Body’s Housecleaning Mechanism to Target Undruggable Proteins
Advocating for the Extension of Healthy Life
Using Donated Living Skin as an Alternative to Animal Testing
A Platform to Scale the Production of Personalized Cell Therapies
Developing Small Molecule Therapies to Target Proteins Only Biologics Have Been Able to Hit
Targeting Solid Tumors with Oncolytic Viruses
Reinventing the Discovery and Cell Line Development of Biotherapeutics
Engineering Off-the-Shelf Cell Therapies to Target Solid Tumors
Democratizing Drug Discovery
Scaling Genetic Counseling Services with AI
Programming Cell Therapies to Overcome Solid Tumor Defense Systems
Using Liquid Biopsies to Diagnose Infectious Diseases
Striking Hepatitis B at Its Core
Modulating Serotonin with Psychedelics to Treat Neuropsychiatric Conditions
A Procedural Therapy Seeks to Address Type 2 Diabetes at Its Root Cause
Building a Better Path to Neurotherapeutics
Taking a Portfolio Approach to Immuno-Oncology
Engineering Life to Reach New Worlds
Targeting Cancer Drug Side Effects at Their Source
Mapping the Universe of Human Proteins
Fighting Disease by Modulating the Translation of Proteins
Fixing Biopharma’s R&D Productivity by Taking a Cue from the Tech Industry
An Affordable and Widely Available Drug Offers Global Hope against COVID
A Gene Therapy to Program the Body to Produce a Treatment for Osteoarthritis
A Test for Data-Driven Drug Development
Bridging the Gulf Between the Promise and Reality of Precision Health
Using Synthetic Biology to Craft One-Time, Programmable mRNA Therapeutics
Using a Digital Cognitive Behavior Therapy to Treat Diabetes and Heart Disease
Disrupting Pain Signals with Precision
A Diagnostics Company Moves to Developing Precision Cancer Therapies
Characterizing the Immunome at Scale
Delivering Oxygen to Tissue in Need
Using Gene Therapy to Create a Drug Biofactory within a Patient
Finding New Uses for TNF Inhibitors
Using AI to Map the Undiscovered World of Bioactive Compounds in Plants
Improving the Delivery of Drugs through Thin Film Freezing
Using CRISPR to Target RNA Instead of DNA
An Antisense Pioneer Brings Custom Treatments to Patients with Ultra-Rare Conditions
Managing Neurodegenerative Diseases with Better Data to Improve Outcomes
A Small Molecule Cancer Drug That Promotes an Adaptive Immune Response